Nitin Nitin to Antibodies, Neoplasm
This is a "connection" page, showing publications Nitin Nitin has written about Antibodies, Neoplasm.
Connection Strength
0.479
-
Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2014 Nov; 167(4):487-99.
Score: 0.479